Ausgabe 2/2003
Inhalt (11 Artikel)
Editorial Board
Should ACE Inhibition Always be First-Line Therapy in Heart Failure? Lessons from the CARMEN Study
Willem J. Remme
Functional Role of Potassium Channels in the Vasodilating Mechanism of Levosimendan in Porcine Isolated Coronary Artery
János Pataricza, Irén Krassói, József Höhn, Attila Kun, Julius Gyula Papp
Prevention of Nitrate Tolerance by Long-Term Treatment with Statins
David Fontaine, Anne Otto, Jeanine Fontaine, Guy Berkenboom
Role of Oral Blockade of Platelet Glycoprotein IIb/IIIa on Neutrophil Activation in Patients with Acute Coronary Syndromes
Carlos V. Serrano Jr., José C. Nicolau, Margareth Venturinelli, Luciano M. Baracioli, Robert J. Anders, Christopher P. Cannon, José A. F. Ramires
The Effect of Quinapril on Functional Status of Elderly Patients with Diastolic Heart Failure
Min Zi, Neil Carmichael, Michael Lye
Multicenter Prospective Investigation on Cardiovascular Adverse Effects of Tacrolimus in Kidney Transplantations
Yoshihiko Seino, Masatsugu Hori, Takao Sonoda
Evolution and Cost Trends of Antihypertensive and Hypolipidaemic Drug Treatment in France
Pedro Marques-Vidal, Michèle Montaye, Jean-Bernard Ruidavets, Philippe Amouyel, Jean Ferrières
Letter to the Editor
A High Incidence of Vitamin B12 Deficiency in Israeli Patients Undergoing Coronary Angiography
Sorel Goland, Oded Ayzenberg, Fabio Kuznitz, Sara Shimoni, Avraham Caspi, Stephen Malnick